LONG BEACH, Calif.--(BUSINESS WIRE)--Mar. 3, 2022--
The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced Andrew Stanleick, President and Chief Executive Officer, and Liyuan Woo, Chief Financial Officer, will participate in the following upcoming investor conferences:
Raymond James 43rd Annual Institutional Investors Conference
Presentation Date: Tuesday, March 8, 2022, 4:35 p.m. ET
DA Davidson 5th Annual Consumer Growth Conference
Presentation Date: Thursday, March 10, 2022, 8:00 a.m. ET
The presentations will be available on the Company’s investor relations website at https://investors.beautyhealth.com/. An archived replay of the webcasts will be available following the live presentations.
About The Beauty Health Company
The Beauty Health Company is a global category-creating company focused on delivering beauty health experiences by reinventing our consumer’s relationship with their skin, their bodies and their self-confidence. Our flagship brand, HydraFacial, created the category of hydradermabrasion by using a patented Vortex-Fusion Delivery System to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. HydraFacial provides a non-invasive and approachable experience with a powerful community of a/estheticians, consumers and partners, bridging medical aesthetics to beauty to democratize and personalize skin care solutions across ages, genders, skin tones, and skin types. HydraFacial is available in over 90 countries with an install base of 20,399 Delivery Systems providing millions of experiences to consumers each year. For more information, please visit www.beautyhealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220303005023/en/
ICR, Inc.
Investors: Dawn Francfort
Email: BeautyHealthIR@icrinc.com
Press: Alecia Pulman
Email: BeautyHealth@icrinc.com
Source: The Beauty Health Company